Aligned Genetics Inc - Asset Resilience Ratio

Latest as of September 2025: 2.22%

Aligned Genetics Inc (238120) has an Asset Resilience Ratio of 2.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩1000.00 Million

≈ $677.69K USD Cash + Short-term Investments

Total Assets

₩45.11 Billion

≈ $30.57 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Aligned Genetics Inc's Asset Resilience Ratio has changed over time. Check 238120 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Aligned Genetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Aligned Genetics Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1000.00 Million	2.22%
Total Liquid Assets	₩1000.00 Million	2.22%

Asset Resilience Insights

Limited Liquidity: Aligned Genetics Inc maintains only 2.22% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Aligned Genetics Inc Industry Peers by Asset Resilience Ratio

Compare Aligned Genetics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Aligned Genetics Inc (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Aligned Genetics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	21.88%	₩9.69 Billion ≈ $6.56 Million	₩44.28 Billion ≈ $30.00 Million	+18.97pp
2023-12-31	2.90%	₩1.19 Billion ≈ $804.80K	₩40.93 Billion ≈ $27.74 Million	-8.63pp
2022-12-31	11.53%	₩4.25 Billion ≈ $2.88 Million	₩36.90 Billion ≈ $25.01 Million	-11.27pp
2021-12-31	22.80%	₩7.86 Billion ≈ $5.33 Million	₩34.47 Billion ≈ $23.36 Million	-24.84pp
2020-12-31	47.64%	₩12.14 Billion ≈ $8.23 Million	₩25.48 Billion ≈ $17.27 Million	-8.82pp
2019-12-31	56.46%	₩13.90 Billion ≈ $9.42 Million	₩24.62 Billion ≈ $16.68 Million	+26.38pp
2018-12-31	30.07%	₩6.92 Billion ≈ $4.69 Million	₩23.00 Billion ≈ $15.59 Million	-50.19pp
2017-12-31	80.26%	₩19.51 Billion ≈ $13.22 Million	₩24.31 Billion ≈ $16.47 Million	-3.13pp
2016-12-31	83.39%	₩21.56 Billion ≈ $14.61 Million	₩25.86 Billion ≈ $17.53 Million	+79.15pp
2015-12-31	4.23%	₩290.44 Million ≈ $196.83K	₩6.86 Billion ≈ $4.65 Million	--

pp = percentage points

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$27.72 Million

₩40.91 Billion KRW

Market Cap Rank

#23974 Global

#1647 in Korea

Share Price

₩2910.00

Change (1 day)

+1.75%

52-Week Range

₩2680.00 - ₩6050.00

All Time High

₩7875.00